STOCK TITAN

AIBOTICS INC (AIBT) Financials

AIBT
FY2025 annual
Revenue $2K YoY not available
Net Income -$2.2M -19.9% YoY
Operating Cash Flow -$458K -76.9% YoY
Gross Profit $2K YoY not available
Market Cap $1.9M as of Oct 19, 2026
Price / Sales 856x on $2K revenue, FY2025
Price / Earnings n/m net loss, so no earnings multiple, FY2025
Price / Book n/m negative shareholder equity, so no book multiple, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 19, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AIBT SEC filings page.

AIBOTICS INC (AIBT) reported $2K in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AIBT FY2025

The numbers describe a business with nominal revenue, losses funded partly by financing, and liabilities far exceeding assets.

In FY2025, $2K of revenue sat beside $1.8M of selling and administrative expense, so the reported loss reflects a cost base operating far ahead of commercial activity rather than a conventional margin story. Operating cash flow was -$458K while financing supplied $529K, indicating that reported cash movement depended on external funding rather than internally generated cash.

The capital structure is heavily burdened: $4.8M of liabilities against $875K of assets leaves negative equity. A 0.1x current ratio also indicates that reported current assets were far below near-term obligations, making liquidity a balance-sheet constraint rather than an operating strength.

Revenue was only $2K in FY2025 after $0 in FY2024, leaving the expense base unsupported by meaningful sales. The reported liquidity measure was 6.7 months of FY2025 operating outflow, but that comparison does not change the more fundamental pattern: the business was still spending ahead of revenue generation.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

AIBOTICS INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress
-33.78

AIBOTICS INC scores -33.78, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($1.9M) relative to total liabilities ($4.8M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/7

AIBOTICS INC passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality No Cash Backing
N/A

AIBOTICS INC reported a net loss of $2.2M while operations used $458K of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

AIBOTICS INC reported an operating loss of $1.8M against $227K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$0

AIBOTICS INC generated $0 in revenue in Q2 2026.

EBITDA
-$414K
YoY-14.7%
QoQ-15.1%

AIBOTICS INC's EBITDA was -$414K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 14.7% from the same quarter a year earlier. Against the prior quarter it is down 15.1%.

Net Income
-$537K
YoY-10.5%
QoQ-28.4%

AIBOTICS INC reported -$537K in net income in Q2 2026. This represents a decrease of 10.5% from the same quarter a year earlier. Against the prior quarter it is down 28.4%.

EPS (Diluted)

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt
$233K
YoY-3.6%
QoQ-19.2%
5Y CAGR-14.6%

AIBOTICS INC held $233K in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding
850M
QoQ+49.8%
5Y CAGR+131.0%

AIBOTICS INC had 850M shares outstanding in Q2 2026. Against the prior quarter it is up 49.8%.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

None of these metrics is reported for Q2 2026.

Capital Allocation

None of these metrics is reported for Q2 2026.

AIBT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AIBT quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$0$0-100.0%N/A$0$0$2.2MN/A$0
Gross Profit$0$0-100.0%N/A$0$0$2.2MN/A$0
SG&A Expenses$414K+14.7%$359K-99.9%N/A$480K+24.7%$361K-7.9%$531.6M+147222.9%N/A$385K+132.9%
Operating Income-$414K-14.7%-$359K+99.9%N/A-$480K-24.7%-$361K+7.9%-$529.5M-146617.9%N/A-$385K-132.9%
EBITDA-$414K-14.7%-$359K+99.9%N/A-$480K-24.7%-$361K+7.8%-$529.2M-146650.2%N/A-$385K-133.3%
Interest Expense$47K-33.0%$59K-99.9%N/A$11K-85.1%$70K-11.6%$61.9M+95079.0%N/A$75K-47.7%
Income Tax$0$0N/A$0$0$0N/A$0
Net Income-$537K-10.5%-$418K+99.9%N/A-$530K-15.2%-$486K-3.3%-$591.4M-138744.5%N/A-$460K-49.1%

Not reported in any period shown, so not listed: Cost of Revenue, R&D Expenses, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

AIBT Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AIBT quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$550K-53.6%$771K-99.9%$875K-40.0%$1.0M-38.1%$1.2M-37.2%$1.3B+58849.3%$1.5M-34.4%$1.6M+417.0%
Current Assets$276K+13.8%$331K-99.8%$270K+45.9%$241K+18.9%$242K-13.6%$156.7M+42155.7%$185K-33.7%$203K-35.9%
Cash & Equivalents$233K-3.6%$289K-99.8%$256K+38.3%$230K+13.9%$242K-13.5%$156.7M+42212.7%$185K-33.7%$202K-36.2%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$41K$41K$0N/AN/AN/AN/AN/A
Long-Term Investments$0$0$0$0$0$0$0$0
Total Liabilities$5.2M-4.5%$5.1M-99.9%$4.8M-0.3%$4.9M-2.0%$5.4M+12.1%$5.1B+110819.9%$4.9M+14.2%$5.0M+143.4%
Current Liabilities$5.2M-4.5%$5.1M-99.9%$4.8M-1.2%$4.9M-2.0%$5.4M+12.1%$5.1B+110819.9%$4.9M+14.2%$5.0M+143.4%
Non-Current Liabilities$0$0$41K$0$0$0+100.0%$0$0
Total Equity-$4.6M-9.4%-$4.3M+99.9%-$4.0M-16.7%-$3.9M-15.7%-$4.2M-43.9%-$3.8B-156239.7%-$3.4M-67.4%-$3.4M-93.3%
Retained Earnings-$14.0M-17.6%-$13.4M+99.9%-$13.0M-20.5%-$12.4M-20.3%-$11.9M-20.6%-$11.4B-121352.5%-$10.8M-20.6%-$10.3M-19.0%

Not reported in any period shown, so not listed: Accounts Receivable, Goodwill, Long-Term Debt.

AIBT Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AIBT quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow-$47K+71.4%-$36K+99.9%-$87K-401.7%-$179K-130.5%-$165K-81.8%-$28.4M-38375.6%-$17K+54.4%-$78K-254.0%
Depreciation & Amortization$0$0-100.0%$0$0$0-100.0%$249K+99900.0%$0-100.0%$0-100.0%
Investing Cash Flow$0$0N/AN/A$0$0N/A$0
Financing Cash Flow-$8K-103.4%$69K$112K$167K$250K$0-100.0%$0$0

Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

AIBT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AIBT quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Gross MarginN/AN/AN/AN/AN/A100.0%N/AN/A
Operating MarginN/AN/AN/AN/AN/A-24254.0%N/AN/A
Net MarginN/AN/AN/AN/AN/A-27091.0%N/AN/A
Return on Assets-97.7%-56.7pp-54.2%-7.4ppN/A-52.1%-24.1pp-41.0%-16.1pp-46.8%-26.9ppN/A-28.0%+69.2pp
Current Ratio0.050.0x0.070.0x0.060.0x0.050.0x0.040.0x0.030.0x0.040.0x0.04-0.1x
Asset Turnover0.000.0x0.000.0xN/A0.000.0x0.000.0x0.000.0xN/A0.00

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Note: Shareholder equity is negative (-$4.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.06), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
AIBOTICS INC AIBT FY2025 $2K -$2.2M N/A $1.9M —
LADRX CORPORATION LADX FY2024 N/A -$1.6M N/A $579K —
BIO-PATH HOLDINGS INC BPTH FY2024 N/A -$9.9M N/A N/A —
REGEN BIOPHARMA INC RGBP FY2025 $237K -$1.3M N/A $168K —

Frequently Asked Questions

What is AIBOTICS INC's annual revenue?

AIBOTICS INC (AIBT) reported $2K in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is AIBOTICS INC profitable?

No, AIBOTICS INC (AIBT) reported a net income of -$2.2M in fiscal year 2025.

What is AIBOTICS INC's EBITDA?

AIBOTICS INC (AIBT) had EBITDA of -$1.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

AIBOTICS INC (AIBT) had a gross margin of 100.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

AIBOTICS INC (AIBT) recorded an outflow of $458K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

AIBOTICS INC (AIBT) had $875K in total assets as of fiscal year 2025, including both current and long-term assets.

AIBOTICS INC (AIBT) had 568M shares outstanding as of fiscal year 2025.

AIBOTICS INC (AIBT) had a current ratio of 0.06 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

AIBOTICS INC (AIBT) had a return on assets of -253.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

AIBOTICS INC (AIBT) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $1.9M as of Oct 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

AIBOTICS INC (AIBT) trades at 856x sales, its market capitalization divided by revenue of $2K revenue, FY2025. The market capitalization is $1.9M as of Oct 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, AIBOTICS INC (AIBT) held $256K in cash, cash equivalents and investments, and reported an operating cash outflow of $458K over that year. Dividing the one by the other, the reported balance equals about 7 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

AIBOTICS INC (AIBT) has negative shareholder equity of -$4.0M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

AIBOTICS INC (AIBT) has an Altman Z-Score of -33.78, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

AIBOTICS INC (AIBT) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

AIBOTICS INC (AIBT) reported a net loss of $2.2M while operations used $458K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

AIBOTICS INC (AIBT) reported an operating loss of $1.8M against $227K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top